Technology area: Chemistry & Materials
4 pending office actions • 3 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 5 patents granted in the last 365 days
Louis Dreyfus Company Plant Proteins LLC has 4 pending office actions in Chemistry & Materials. The matters involve 4 distinct examiners but 3 distinct art units, so examiner distribution is broader than art-unit distribution.
LE, EMILY M is the identified busiest examiner. The pending work is not concentrated in that examiner, which suggests that prosecution review should account for multiple examiner interactions while tracking the shared technical classifications.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (25%) |
| §103 only | 1 (25%) |
| Multi-statute (no §101) | 2 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WATTS, JENNA A | 1 | 48.6% | +54.0% |
| LE, EMILY M | 1 | 17.9% | -3.7% |
| TRAN, LIEN THUY | 1 | 28.7% | +26.5% |
| GWARTNEY, ELIZABETH A | 1 | 36.0% | +34.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18614211 | METHODS OF USING A NOVEL ANIMAL FEED | GWARTNEY, ELIZABETH A | 56d |
| 18792418 | Oil Seed Protein Isolate and Process for Production | WATTS, JENNA A | — |
| 18792408 | SUNFLOWER PROTEIN ISOLATE AND PROCESS FOR PRODUCTION | LE, EMILY M | — |
| 18792399 | Canola Protein Concentrate and Process for Production | TRAN, LIEN THUY | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18614211 | METHODS OF USING A NOVEL ANIMAL FEED | GWARTNEY, ELIZABETH A | 56d |
| 18792418 | Oil Seed Protein Isolate and Process for Production | WATTS, JENNA A | — |
| 18792399 | Canola Protein Concentrate and Process for Production | TRAN, LIEN THUY | — |
| Art Unit | Apps |
|---|---|
| 1791 | 1 |
| 1793 | 1 |
| 1759 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18792418 | Oil Seed Protein Isolate and Process for Production | WATTS, JENNA A | 1791 | §102§103§112 | Non-Final OA | — | Pending | Aug 01, 2024 |
| 18792408 | SUNFLOWER PROTEIN ISOLATE AND PROCESS FOR PRODUCTION | LE, EMILY M | — | §103Other | Non-Final OA | — | Pending | Aug 01, 2024 |
| 18792399 | Canola Protein Concentrate and Process for Production | TRAN, LIEN THUY | 1793 | §103§112 | Non-Final OA | — | Pending | Aug 01, 2024 |
| 18614211 | METHODS OF USING A NOVEL ANIMAL FEED | GWARTNEY, ELIZABETH A | 1759 | §101§103§112 | Non-Final OA | 56d | Pending | Mar 22, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialLouis Dreyfus Company Plant Proteins LLC has 4 pending office actions as of October 2026, spread across 3 art units and 4 examiners.
Jenna A Watts has the most, with 1 of Louis Dreyfus Company Plant Proteins LLC's pending office actions.
Mostly Chemistry & Materials (USPTO Tech Center 1700), based on where its pending office actions are examined.
